BridgeBio Pharma, Inc. (BIT:1BBIO)
Italy · Delayed Price · Currency is EUR 60.66
+1.46 (2.47%)
Last updated: Feb 9, 2026, 3:43 PM CET
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of €11.74 billion as of February 11, 2026. Its market cap has increased by 77.83% in one year.
Market Cap
11.74B
Enterprise Value
12.76B
Revenue
301.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
€60.66
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from 2.92B to 11.74B, an increase of 301.79%. That is a compound annual growth rate of 23.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 11.74B | -6.52% |
| Dec 31, 2025 | 12.55B | 150.63% |
| Dec 31, 2024 | 5.01B | -21.16% |
| Dec 29, 2023 | 6.35B | 496.14% |
| Dec 30, 2022 | 1.07B | -50.63% |
| Dec 31, 2021 | 2.16B | -69.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mediobanca Banca di Credito Finanziario | 15.41B |
| Banca Mediolanum | 14.53B |
| Moncler | 13.79B |
| Telecom Italia | 13.69B |
| Unipol Assicurazioni | 13.60B |
| FinecoBank Banca Fineco | 12.30B |
| Edison | 11.37B |
| Italgas | 10.96B |